LanthaScreen™ TR-FRET BACE1 Assay Kit
Product Image
Invitrogen™

LanthaScreen™ TR-FRET BACE1 Assay Kit

BACE1 (beta-secretase) is a key enzyme involved in the production of amyloid beta-peptides found in extracellular amyloid plaques of Alzheimer'sRead more
Have Questions?
Catalog NumberQuantity
PV4748800 x 20 μL Assays
Catalog number PV4748
Price (EUR)
1.462,00
Each
Add to cart
Quantity:
800 x 20 μL Assays
Price (EUR)
1.462,00
Each
Add to cart

BACE1 (beta-secretase) is a key enzyme involved in the production of amyloid beta-peptides found in extracellular amyloid plaques of Alzheimer's disease (AD). In some cases, early-onset familial AD can be attributed to a 'Swedish' mutation in the amyloid precursor protein (APP), which dramatically enhances the cleavage of this protein by BACE1. This and other genetic and pathological evidence has led to therapeutic approaches that focus on the inhibition of BACE1 and other APP-cleaving enzymes, such as gamma-secretase.

Invitrogen's LanthaScreen™ TR-FRET BACE1 assay provides sensitive high-throughput screening for potential inhibitors of beta-secretase. The kit uses a terbium (Tb)-labeled anti-biotin antibody and a fluorescein-labeled BACE1-biotin substrate in a homogeneous TR-FRET assay format (Figure 1).

Contents and Storage:

The LanthaScreen™ TR-FRET BACE1 Assay Kit contains BACE1 protein, fluorescently labeled BACE1 substrate, Tb-labeled anti-biotin antibody, and buffers. Store components as indicated in the assay protocol (-80°C, -20°C, or +4°C).

For Research Use Only. Not for use in diagnostic procedures.
Specifications
Assayβ-Secretase Assay
For Use With (Application)TR-FRET
Product LineLanthaScreen
Quantity800 x 20 μL Assays
Shipping ConditionDry Ice
Substrate PropertiesPeptide-Based Substrate
Substrate TypeBeta Secretase Substrate
TargetBeta Secretase (BACE1)
Unit SizeEach
Contents & Storage
Store in freezer (-5°C to -30°C).

Frequently asked questions (FAQs)

How does the LanthaScreen technology compare to other TR-FRET assay formats?

We performed a comparison between the LanthaScreen assay and other commercially available TR-FRET assays from 2 different suppliers for the PKC kinase target. Our data revealed that the assays performed comparably, but that the LanthaScreen assay was simpler to optimize and contained fewer components that required optimization. The LanthaScreen assay is a two component system, whereas the other assay formats utilize a trimolecular mechanism which is more time consuming to optimize and has added costs.

For my kinase assay, can I pre-mix the Tb-Ab and EDTA so that I can stop the kinase assay and begin detection with a single reagent addition?

Yes, this is possible depending on the concentrations of reagents used and the time for which they are mixed. We recommend developing and optimizing the assay by using separate reagent additions, because this method will work under the widest range of conditions. Once the assay is optimized, the performance of the assay using pre-mixed antibody and EDTA can be evaluated. We have successfully developed robust assays in which the antibody and EDTA were pre-mixed and then stored overnight at 4 degrees C prior to use the following day. A loss of signal intensity was observed in this case, however, by using the ratiometric readout, this effect was minimal.

Are the LanthaScreen reagents stable to interference from Mg2+, Mn2+, and EDTA?

The chelate is completely stable to Mg2+. The amount of Mn2+ or EDTA that the chelate can tolerate depends largely on how long they are mixed together and the combination of additives used in the reaction. If a reaction requires either Mg2+ or Mn2+ for activation, it is best to stop the reaction by adding an equimolar amount (or slight excess) of EDTA to chelate the metal ions present. This will then essentially eliminate any interference on the terbium chelate by EDTA or Mn2+. Regardless, when LanthaScreen assays are performed using a ratiometric readout (division of the acceptor signal by the donor signal), any interference caused by Mn2+ or EDTA is largely cancelled out.

What is the optimal and/or maximum distance for a Tb-fluorescein pair?

The Förster radius, the distance at which energy transfer efficiency is half-maximal, is around 50-angstroms for the terbiumÆ fluorescein pair. However, the Förster radius does not give a complete indication of energy transfer efficiency when using long lifetime fluorophores such as terbium chelates. When using terbium chelates, energy transfer efficiency is determined by the distance of closest approach between the donor and acceptor during the excited state lifetime of the donor. In many assay systems, such as those designed using antibodies or peptides, there is a large degree of conformational freedom that allows the donor and acceptor to approach one another, effectively enhancing the FRET signal. Additionally, it is important to note that as the donor/acceptor pair approach one another and the efficiency of energy transfer increases, the fluorescent lifetime decreases to a comparable extent. From a practical standpoint, this means that when energy transfer is extremely efficient, FRET cannot be measured in time-resolved mode (because the energy transfer is complete before the measurement is made). This is another reason why TR-FRET assays based around terbium-labeled antibodies or streptavidin perform so well, because there exist a range of donor/acceptor distances, several of which are optimal for measuring FRET.

How many LanthaScreen assays can I run with a given amount of substrate?

It varies, depending on the concentration of substrate used in the assay. But in general, for the peptide substrates, 1 mg of peptide will run approximately 250,000 wells (10 µL reaction, 200 nM peptide). For Poly GT or GAT, the 1 mL of 30 µM size we sell is approximately 1 mg. With these substrates, 1 mL of 30 µM will run approximately 16,700 wells (10 µL reaction, 200 µM substrate).

20 nmol of our physiological protein substrates is sufficient for approximately 10,000 wells (10 µL reaction, 200 µM substrate).